Jornada; Regulación europea IVDR para tecnologías de diagnóstico In vitro CNIO, Melchor Fernández Almagro 3, 28029 Madrid y On-Line España Del 27/04/2023 09:00 to 27/04/2023 13:00 Healthcare Access to innovation In vitro diagnostics
ORYZON announces First Patient In in FRIDA, a Phase Ib trial with iadademstat in relapsed/... 15/03/2023 Healthcare Access to innovation Primary objectives: to assess safety, tolerability and RP2D Partners - Oryzon Genomics
Jornada de innovación abierta con la farmacéutica japonesa FUSO Virtual Japón Del 24/04/2023 to 28/04/2023 Healthcare Access to innovation International
Jornada de innovación abierta con la farmacéutica japonesa DyDo Virtual Japón Del 29/05/2023 to 02/06/2023 Healthcare Access to innovation International
#NewMember | "AseBio is the Ágora from which to connect with other people and companies in... 13/03/2023 Access to innovation Meet Genios y Talentos, our new member. We talked to Egoitz Calvo Gracia, Project Coordinator of the company. AseBio
ORYZON announces clinical candidate nomination of ORY-4001 for the treatment of CNS disord... 13/03/2023 Healthcare Access to innovation Corporate Rescues motor-neuronal deficiencies in a Charcot-Marie-Tooth model Partners - Oryzon Genomics
BIOLAN HEALTH receives the start-up Medtech 2022 Tecnalia Award 07/03/2023 Access to innovation Corporate The first edition of the Medtech 2022 Tecnalia awards was held on 14 February in Donostia Partners
AptaTargets receives PRIME designation from the European Medicines Agency for ApTOLL in is... 06/03/2023 Healthcare Access to innovation Corporate AptaTargets has obtained priority medicines (PRIME) designation from the European Medicines Agency (EMA) for the... Partners - AptaTargets
Biolan receives the Award for “Best Start-Up trajectory” at the On Bizkaia 2023 Awards 02/03/2023 Healthcare Access to innovation Corporate The Lifetime Achievement award is given to a startup and a spinoff that have been supported by the regional programme... Partners - Biolan
Asia Bio Partnering Forum 2023 Híbrido: April 26–27, 2023 Singapore - & May 4–5, 2023 Virtual Singapore Del 26/04/2023 to 05/05/2023 Access to innovation
